Get the Stockscreener App
2.02
4.27%
-0.09
After Hours:
2.02
Enveric Biosciences Inc stock is traded at $2.02, with a volume of 34,061.
It is down -4.27% in the last 24 hours and down -47.12% over the past month.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
See More
Previous Close:
$2.11
Open:
$2.13
24h Volume:
34,061
Relative Volume:
0.06
Market Cap:
$2.81M
Revenue:
-
Net Income/Loss:
$-15.08M
P/E Ratio:
-0.3146
EPS:
-6.42
Net Cash Flow:
$-11.56M
1W Performance:
-23.19%
1M Performance:
-47.12%
6M Performance:
-84.27%
1Y Performance:
-89.35%
1-Day Range:
$1.96
$2.16
1-Week Range:
$1.96
$2.59
52-Week Range:
$1.96
$54.00
Enveric Biosciences Inc Stock (ENVB) Company Profile
Name
Enveric Biosciences Inc
Sector
Industry
Phone
239-302-1707
Address
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE
Compare ENVB vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENVB
Enveric Biosciences Inc
|
2.02 | 2.93M | 0 | -15.08M | -11.56M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Enveric Biosciences Inc Stock (ENVB) Latest News
Enveric Biosciences Nears Key Clinical Milestone with Novel Drug Candidate - AD HOC NEWS
Enveric Biosciences (ENVB) Files for Share Sale to Investors - GuruFocus
US Market Wrap: Is PEBK benefiting from innovation trendsMarket Volume Report & Daily Profit Maximizing Tips - baoquankhu1.vn
Enveric Biosciences Expands At-The-Market Equity Offering Capacity - The Globe and Mail
Growth Report: What is Enveric Biosciences Incs book value per shareWeekly Trade Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Can Enveric Biosciences Inc sustain its profitabilityJobs Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Analyst Calls: Is Enveric Biosciences Inc a good ESG investmentQuarterly Market Summary & Safe Capital Investment Plans - baoquankhu1.vn
Fed Meeting: Can Magnite Inc grow without external fundingJuly 2025 Reactions & Verified Momentum Watchlists - baoquankhu1.vn
Enveric Biosciences registers $1.35 million in new shares under ATM agreement - Investing.com UK
Enveric Biosciences registers $1.35 million in new shares under ATM agreement By Investing.com - Investing.com India
Enveric Biosciences Registers Additional Shares for ATM Offering - TradingView
Enveric Biosciences (NASDAQ:ENVB) Trading Down 7.4% – Should You Sell? - Defense World
Enveric Biosciences Inc. (ENVB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Enveric licenses RCANN trademark portfolio to TOTEC Pharma By Investing.com - Investing.com South Africa
Enveric Biosciences (ENVB) Licenses Trademark Portfolio to Totec Pharma - GuruFocus
Enveric Biosciences closes $1.5 million registered direct offering By Investing.com - Investing.com Australia
Is Enveric Biosciences Inc. being accumulated by smart money2025 Earnings Impact & Daily Technical Stock Forecast Reports - mfd.ru
Enveric licenses RCANN trademark portfolio to TOTEC Pharma - Investing.com
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option - Chartmill
Enveric Biosciences Announces Closing Of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - TradingView
Enveric Biosciences Raises Capital Through Equity Offering - TipRanks
Enveric Biosciences closes $1.5 million registered direct offering - Investing.com
Enveric Biosciences Signs Securities Purchase Agreement With Institutional Investors - TradingView
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Caledonian Record
Enveric to sell 328,802 shares at $4.41 in registered direct offering - TipRanks
Enveric Biosciences raises $1.5 million in registered direct offering By Investing.com - Investing.com Canada
Enveric Biosciences (ENVB) Announces Stock and Warrant Offering - GuruFocus
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Business Wire
US Stocks Recap: Does Enveric Biosciences Inc have high return on assets2025 Support & Resistance & Detailed Earnings Play Strategies - baoquankhu1.vn
Dow Update: Will RPID benefit from rising consumer demand2025 Earnings Impact & Weekly Stock Breakout Alerts - baoquankhu1.vn
Bond Watch: What are the risks of holding Central Plains Bancshares IncPortfolio Value Summary & Short-Term Trading Alerts - baoquankhu1.vn
Technical Analysis: Should I invest in Enveric Biosciences Inc before earningsWeekly Risk Summary & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Rally Mode: Is Enveric Biosciences Inc currently under institutional pressure2025 Price Momentum & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Published on: 2026-01-15 09:34:41 - baoquankhu1.vn
Geopolitics Watch: Can Enveric Biosciences Inc stock hit analyst price targetsJuly 2025 Action & Fast Entry High Yield Tips - Bộ Nội Vụ
Enveric Biosciences secures $3.1M through warrant exercise - MSN
Enveric Biosciences, Inc.Common Stock (NQ: ENVB - FinancialContent
Is Enveric Biosciences Inc. stock overvalued by current metricsDurability and Wear Notes & updated model highlights and notes - ulpravda.ru
Can Enveric Biosciences Inc. (SLZ) stock double in coming yearsJuly 2025 Review & Community Trade Idea Sharing Platform - ulpravda.ru
Why Enveric Biosciences Inc. stock remains resilient2025 Winners & Losers & Technical Pattern Alert System - Улправда
Will Enveric Biosciences Inc. (SLZ) stock benefit from commodity supercycleJuly 2025 Spike Watch & Breakout Confirmation Trade Signals - Улправда
Is Enveric Biosciences Inc. (SLZ) stock supported by free cash flowPortfolio Profit Report & AI Driven Stock Movement Reports - ulpravda.ru
How institutional buying supports Enveric Biosciences Inc. stockQuarterly Performance Summary & Consistent Return Strategy Ideas - ulpravda.ru
Enveric Biosciences trading halted, volatility trading pause - MSN
2026 world cup team news insights: Is Enveric Biosciences Inc. stock affected by interest rate hikes2026 world cup usa national team qualification key players high defensive line odds analysis guide - ulpravda.ru
Is Enveric Biosciences Inc. stock affected by interest rate hikes2026 world cup usa national team qualification defensive leaders set piece tactics match prediction expert opinion - Улправда
Dow Theory LettersEnveric Biosciences, Inc.Common Stock (Nasdaq:ENVB) Stock Quote - FinancialContent
Trading Recap: Is Enveric Biosciences Inc SLZ stock undervalued historicallyJuly 2025 Pullbacks & High Conviction Investment Ideas - moha.gov.vn
Enveric Biosciences Inc. (NASDAQ: ENVB)Share Price and Research - intelligentinvestor.com.au
Insider Sell: Will Enveric Biosciences Inc SLZ stock see insider accumulation2025 Earnings Impact & Long-Term Investment Growth Plans - moha.gov.vn
Enveric Biosciences Inc SLZ Stock Analysis and ForecastReal Estate Investment Trusts & Outstanding Growth Opportunities - earlytimes.in
Enveric Biosciences Inc Stock (ENVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):